TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Octapharma AB
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 1,972,217 | 1,743,787 | 1,976,027 |
Financial expenses | 11,301 | 6,042 | 4,033 |
Earnings before taxes | 79,817 | 74,657 | 88,231 |
EBITDA | 295,199 | 312,708 | 403,466 |
Total assets | 1,332,866 | 1,741,651 | 1,813,642 |
Current assets | 420,907 | 736,279 | 596,227 |
Current liabilities | 339,775 | 263,462 | 282,707 |
Equity capital | 965,381 | 929,384 | 934,295 |
- share capital | 23,648 | 24,381 | 26,190 |
Employees (average) | 984 | 882 | 888 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 72.4% | 53.4% | 51.5% |
Turnover per employee | 2,004 | 1,977 | 2,225 |
Profit as a percentage of turnover | 4.0% | 4.3% | 4.5% |
Return on assets (ROA) | 6.8% | 4.6% | 5.1% |
Current ratio | 123.9% | 279.5% | 210.9% |
Return on equity (ROE) | 8.3% | 8.0% | 9.4% |
Change turnover | 280,838 | -95,715 | -84,173 |
Change turnover % | 17% | -5% | -4% |
Chg. No. of employees | 102 | -6 | 54 |
Chg. No. of employees % | 12% | -1% | 6% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.